ELAN – Elanco Animal Health Incorporated
Float Short %
4.87
Margin Of Safety %
-30
Put/Call OI Ratio
0.3
EPS Next Q Diff
-0.13
EPS Last/This Y
0.2
EPS This/Next Y
0.11
Price
17.91
Target Price
18.64
Analyst Recom
1.8
Performance Q
41.36
Relative Volume
1.19
Beta
1.59
Ticker: ELAN
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-07-28 | ELAN | 14.57 | 0.29 | 0.13 | 12955 |
| 2025-07-29 | ELAN | 14.39 | 0.29 | 2.17 | 12975 |
| 2025-07-30 | ELAN | 14.12 | 0.29 | 0.21 | 13004 |
| 2025-07-31 | ELAN | 13.68 | 0.29 | 50.00 | 13014 |
| 2025-08-01 | ELAN | 13.8 | 0.30 | 0.09 | 13089 |
| 2025-08-04 | ELAN | 14.06 | 0.30 | 0.03 | 12905 |
| 2025-08-05 | ELAN | 14.22 | 0.30 | 0.11 | 12964 |
| 2025-08-06 | ELAN | 13.97 | 0.30 | 0.01 | 12974 |
| 2025-08-07 | ELAN | 16.48 | 0.23 | 0.11 | 16299 |
| 2025-08-08 | ELAN | 16.64 | 0.25 | 0.17 | 16477 |
| 2025-08-11 | ELAN | 17.1 | 0.25 | 0.41 | 16505 |
| 2025-08-12 | ELAN | 17.44 | 0.26 | 0.39 | 16644 |
| 2025-08-13 | ELAN | 17.81 | 0.26 | 0.07 | 16709 |
| 2025-08-14 | ELAN | 18 | 0.26 | 0.01 | 16792 |
| 2025-08-15 | ELAN | 17.95 | 0.19 | 0.02 | 21815 |
| 2025-08-18 | ELAN | 17.69 | 0.31 | 0.06 | 13924 |
| 2025-08-19 | ELAN | 17.52 | 0.31 | 0.09 | 14036 |
| 2025-08-20 | ELAN | 17.46 | 0.31 | 0.02 | 14061 |
| 2025-08-21 | ELAN | 17.5 | 0.30 | 0.78 | 14177 |
| 2025-08-22 | ELAN | 17.91 | 0.30 | 0.12 | 14224 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-07-28 | ELAN | 14.53 | -33.4 | -12.1 | 0.84 |
| 2025-07-29 | ELAN | 14.39 | -33.4 | -5.8 | 0.84 |
| 2025-07-30 | ELAN | 14.12 | -33.4 | -8.6 | 0.84 |
| 2025-07-31 | ELAN | 13.68 | -33.4 | -14.4 | 0.84 |
| 2025-08-01 | ELAN | 13.79 | -33.4 | 4.3 | 0.84 |
| 2025-08-04 | ELAN | 14.07 | -33.1 | 10.1 | 0.84 |
| 2025-08-05 | ELAN | 14.20 | -33.1 | 4.9 | 0.84 |
| 2025-08-06 | ELAN | 13.98 | -33.1 | -6.9 | 0.84 |
| 2025-08-07 | ELAN | 16.48 | -33.1 | 86.9 | 0.84 |
| 2025-08-08 | ELAN | 16.67 | -33.1 | 6.3 | 0.84 |
| 2025-08-11 | ELAN | 17.09 | -33.1 | -26.4 | 0.84 |
| 2025-08-12 | ELAN | 17.44 | 1.7 | -8.9 | 0.88 |
| 2025-08-13 | ELAN | 17.81 | 1.7 | -276.6 | 0.88 |
| 2025-08-14 | ELAN | 17.99 | 1.7 | -280.7 | 0.88 |
| 2025-08-15 | ELAN | 17.94 | 1.7 | -285.5 | 0.88 |
| 2025-08-18 | ELAN | 17.69 | 0.8 | -289.6 | 0.88 |
| 2025-08-19 | ELAN | 17.52 | 0.8 | -287.9 | 0.88 |
| 2025-08-20 | ELAN | 17.46 | 0.8 | -285.5 | 0.88 |
| 2025-08-21 | ELAN | 17.50 | 0.8 | -283.5 | 0.88 |
| 2025-08-22 | ELAN | 17.91 | 0.8 | -275.8 | 0.88 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-07-28 | ELAN | 0.96 | 1.76 | 4.79 |
| 2025-07-29 | ELAN | 0.96 | 1.76 | 4.79 |
| 2025-07-30 | ELAN | 0.96 | 1.76 | 4.79 |
| 2025-07-31 | ELAN | 0.96 | 1.76 | 4.79 |
| 2025-08-01 | ELAN | 0.96 | 1.76 | 4.79 |
| 2025-08-04 | ELAN | 0.96 | 1.41 | 4.79 |
| 2025-08-05 | ELAN | 0.96 | 1.41 | 4.79 |
| 2025-08-06 | ELAN | 0.96 | 1.41 | 4.79 |
| 2025-08-07 | ELAN | 0.96 | 1.41 | 4.79 |
| 2025-08-08 | ELAN | 0.96 | 1.41 | 4.79 |
| 2025-08-11 | ELAN | 0.96 | 1.15 | 4.79 |
| 2025-08-12 | ELAN | 0.96 | 1.15 | 4.87 |
| 2025-08-13 | ELAN | 0.96 | 1.15 | 4.87 |
| 2025-08-14 | ELAN | 0.96 | 1.15 | 4.87 |
| 2025-08-15 | ELAN | 0.96 | 1.15 | 4.87 |
| 2025-08-18 | ELAN | 0.96 | 1.89 | 4.87 |
| 2025-08-19 | ELAN | 0.96 | 1.89 | 4.87 |
| 2025-08-20 | ELAN | 0.96 | 1.89 | 4.87 |
| 2025-08-21 | ELAN | 0.96 | 1.89 | 4.87 |
| 2025-08-22 | ELAN | 0.96 | 1.89 | 4.87 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
0.26
Avg. EPS Est. Current Quarter
0.13
Avg. EPS Est. Next Quarter
0.13
Insider Transactions
0.96
Institutional Transactions
1.89
Beta
1.59
Average Sales Estimate Current Quarter
1092
Average Sales Estimate Next Quarter
1076
Fair Value
12.5
Quality Score
75
Growth Score
48
Sentiment Score
76
Actual DrawDown %
52.2
Max Drawdown 5-Year %
-78
Target Price
18.64
P/E
20.52
Forward P/E
18.15
PEG
2.77
P/S
1.98
P/B
1.31
P/Free Cash Flow
24.65
EPS
0.87
Average EPS Est. Cur. Y
0.88
EPS Next Y. (Est.)
0.99
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
9.68
Relative Volume
1.19
Return on Equity vs Sector %
-18.3
Return on Equity vs Industry %
-1.4
EPS 1 7Days Diff
EPS 1 30Days Diff
0.04
EBIT Estimation
-275.8
Elanco Animal Health IncorporatSector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 9000
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals worldwide. It offers pet health products, such as parasiticides, vaccines, and therapeutics that protect pets from fleas, ticks, and internal parasites under the Seresto, K-9 Advantage, Advantix, and Advocate trademarks; prescription parasiticide products, an over-the-counter treatments for the prevention and elimination of fleas and ticks under the Credelio, Credelio Cat, Credelio Plus, Interceptor Plus, Doncit, Drontal, Drontal Plus, and Trifexis trademarks; vaccines portfolio that provides differentiated prevention coverage for a number of important pet health risks; and therapeutics portfolio for the treatment of pain, otitis, cardiovascular, and dermatology indications, as well as osteoarthritis for dogs and cats under the Galliprant trademark. The company also provides farm animal products that help farmers improve animal health and wellbeing, and raise livestock, such as cattle, swine, and poultry. In addition, it offers medicated feed additives, injectable antibiotics, vaccines, insecticides and enzymes, and others under the Rumensin, Baytril, and Experior trademarks for cattle; and under the Maxiban and Monteban trademarks for the control and prevention of intestinal disease in poultry. Further, the company offers other pet health products for cats and dogs under the Atopica, Milbemax, Onsior, and TruCan trademarks; and other farm animal products for poultry, cattle, and swine under the AviPro, Catosal, Denagard, Hemicell, Pulmotil, and Surmax tradmarks. It sells its products to third-party distributors and independent retailers; and directly to farm animal producers and veterinarians. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana.
stock quote shares ELAN – Elanco Animal Health Incorporated Stock Price stock today
news today ELAN – Elanco Animal Health Incorporated stock forecast ,stock prediction 2023 2024 2025
marketwatch ELAN – Elanco Animal Health Incorporated yahoo finance google finance
stock history ELAN – Elanco Animal Health Incorporated invest stock market
stock prices ELAN premarket after hours
ticker ELAN fair value insiders trading